Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What’s Old is New

Commonly used adjuvant systemic therapies harbor high rates of severe short-term and long-term side effects but are often justified to patients because of curative intent in early stage breast cancer. One of the oldest and least toxic adjuvant regimens, oral cyclophosphamide given with intravenous m...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Breast Cancer
Päätekijät: Cho, Eunpi, Schwemm, Ann, Rubinstein, Lena, Stevenson, Phillip, Gooley, Ted A., Ellis, Georgiana, Specht, Jennifer M., Livingston, Robert B., Linden, Hannah M., Gadi, Vijayakrishna K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4568144/
https://ncbi.nlm.nih.gov/pubmed/26025883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2015.04.002
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia